Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × antineoplaston A10 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Astrocytoma 8 Glioblastoma 5 Prostatic Neoplasms 4 Neuroectodermal Tumors, Primitive 4 Lymphoma, Non-Hodgkin 4 Recurrence 2 Neurocytoma 2 Glioma 2 Breast Neoplasms 2 Brain Neoplasms 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Small Intestine Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rhabdoid Tumor 1 Paranasal Sinus Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neurofibroma 1 Neuroblastoma 1 Neurilemmoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Nasopharyngeal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 14 Hydroxyurea 7 Everolimus 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Radiosurgery 6 Proton Therapy 6 Specimen Handling 5 Bevacizumab 5 pembrolizumab 4 Surveys and Questionnaires 4 Radiotherapy 4 Imatinib Mesylate 4 Cyclophosphamide 4 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Surgical Procedures, Operative 3 Sunitinib 3 Radiotherapy, Intensity-Modulated 3 Observation 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 trametinib 2 fludarabine 2 arginyllysine 2 aldesleukin 2 Yoga 2 Whole Body Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003483 2017-08-24

Antineoplaston Therapy in Treating Patients With Meningioma

Burzynski Research Institute

Phase 2 Terminated

3 enrolled 6 charts

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡